Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dendritic Cell Immunotherapy for Pediatric and Young Adult Solid Tumors
NCT02496520Phase 2Completed
- Sponsor
- Universidad de Navarra
- Start
- Sep 2014
- Primary completion
- Sep 2018
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial in sarcoma and central nervous system tumor, sponsored by Universidad de Navarra. Primary endpoint: Number and type of adverse events at 24 months. Started Sep 2014; status: completed.
02
Conditions
sarcomacentral nervous system tumor
Beyond the preview
Go deeper on NCT02496520.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02496520.